Viewing Study NCT07441993


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-31 @ 1:45 AM
Study NCT ID: NCT07441993
Status: RECRUITING
Last Update Posted: 2026-03-02
First Post: 2026-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Exploratory Study of Orelabrutinib in the Treatment of Early-stage Untreated MZL
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Marginal Zone Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoma View
None Marginal zone lymphoma View
None Orelabrutinib View